← Back to Search

Implementation Support for Prevention Program Delivery by College Peer Educators for Eating Disorders (PI Trial)

N/A
Waitlist Available
Led By Eric Stice, PhD
Research Sponsored by Oregon Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months, 24 months
Awards & highlights

PI Trial Summary

This trial will compare three ways of implementing a college prevention program for mental illness.

Eligible Conditions
  • Eating Disorders

PI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months, 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months, 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Competence of Program Implementation as assessed by 12-item Group Leader Competence Scale (Stice et al., 2013a)
Fidelity of Program Implementation as assessed by 25-item Session Adherence Scale (Stice et al., 2013a)
Secondary outcome measures
Attendance
Delivery Cost
Implementation Progress
+9 more

PI Trial Design

3Treatment groups
Experimental Treatment
Group I: Training, Tech. Assist., Qual. AssuranceExperimental Treatment1 Intervention
This condition involves an intensive 2-day initial train-the-trainer workshop that simultaneously trains peer educators to deliver the intervention and campus supervisors to train and support future peer educators, plus the facilitator guide and facilitator support website. This condition additionally contains a 1/2 day implementation training to articulate goals, needs, leadership structure, adoption options, recruitment strategies and communication. Furthermore, this condition will have 1 year of technical assistance, coaching, and quality assurance to enhance implementation skills and sustainability.
Group II: Training and Technical AssistanceExperimental Treatment1 Intervention
This condition involves an intensive 2-day initial train-the-trainer workshop that simultaneously trains peer educators to deliver the intervention and campus supervisors to train and support future peer educators, plus the facilitator guide and facilitator support website. This condition additionally contains a 1/2 day implementation training to articulate goals, needs, leadership structure, adoption options, recruitment strategies, and communication.
Group III: Training AloneExperimental Treatment1 Intervention
This condition involves an intensive 2-day initial train-the-trainer workshop that simultaneously trains peer educators to deliver the intervention and campus supervisors to train and support future peer educators, plus the facilitator guide and facilitator support website.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Training
2008
Completed Phase 4
~3310
Training and Technical Assistance
2018
N/A
~2270
Training, Tech. Assistance, Quality Assurance/Improvement
2018
N/A
~2270

Find a Location

Who is running the clinical trial?

Oregon Research InstituteLead Sponsor
84 Previous Clinical Trials
64,006 Total Patients Enrolled
8 Trials studying Eating Disorders
2,485 Patients Enrolled for Eating Disorders
Stanford UniversityOTHER
2,396 Previous Clinical Trials
17,339,294 Total Patients Enrolled
19 Trials studying Eating Disorders
6,751 Patients Enrolled for Eating Disorders
University of Texas at AustinOTHER
353 Previous Clinical Trials
78,983 Total Patients Enrolled
2 Trials studying Eating Disorders
882 Patients Enrolled for Eating Disorders

Media Library

Training Clinical Trial Eligibility Overview. Trial Name: NCT03409809 — N/A
Eating Disorders Research Study Groups: Training Alone, Training and Technical Assistance, Training, Tech. Assist., Qual. Assurance
Eating Disorders Clinical Trial 2023: Training Highlights & Side Effects. Trial Name: NCT03409809 — N/A
Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT03409809 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the hoped-for outcomes of this medical experiment?

"This clinical trial will measure the efficacy of a particular program over 12 months by way of assessing Group Leader Competence with the use of a 12-item scale. Secondary metrics include Delivery Cost, Implementation Progress, and Perceived Characteristics of Intervention as evaluated through questionnaires rating from 1 to 5 on a Likert-type Scale ranging from 27 to 135."

Answered by AI

Is this trial accessible to participants at present?

"Contrary to what is indicated on clinicaltrials.gov, this research project has ceased recruitment of participants; the trial was first made available in January 2018 and last edited in December 2022. However, there are an additional 98 experiments actively recruiting patients at present."

Answered by AI

What is the current geographic scope of this investigation?

"Currently, Stanford University in Stanford, the University of Texas at Austin in Austin, and Trinity University in San Antonio are seeking participants. Additionally, 4 other medical centres have opened their doors for recruitment."

Answered by AI
~312 spots leftby May 2025